Efficacy and safety of a recombinant factor IX (Bax326) in previously treated patients with severe or moderately severe haemophilia B undergoing surgical or other invasive procedures: a prospective, open-label, uncontrolled, multicentre, phase III study - Windyga, J; Lissitchkov, T; Stasyshyn, O (Haemophilia, 2014)
et al.